Senno Therapeutics Accelerates Development of Cell Therapy Using iPS Cell-Derived Hepatoblast Cells
Senno Therapeutics, a Tokyo-based bioventure, is developing innovative cell therapies for fatal live… · 2026-04-15
Senno Therapeutics, a Tokyo-based bioventure, is developing innovative cell therapies for fatal live… · 2026-04-15
Senno Therapeutics, aiming to resolve unmet medical needs in liver failure, raised funds totaling 75… · 2026-04-14